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Abstract: Background The optimal timing of the drain removal after gastrectomy has been 
unclear. The aim of this prospective randomized controlled study was to assess the optimal 
timing of removal of prophylactic drains after distal gastrectomy (DG) or pylorus-preserving 
gastrectomy (PPG). 
Methods : All patients undergoing DG or PPG for gastric cancer were eligible for this study. 
The exclusion criteria were combined organ resection, the use of postoperative anticoagulant 
therapy, intraoperative injury of other organs and anastomotic problems. Just after the 
operation, the eligible patients were randomly assigned to either the early removal group (n 
= 50), where the drain was removed in the morning of the postoperative day (POD) 1, or the 
control group (n = 50), where the drain was removed on POD 3 or later. We compared the 
surgical outcomes between the groups. 
Results : The rate of overall postoperative complications was 18% in the early removal group 
and 18% in the control group, with no significant difference between the groups. The severity 
of complications was also similar between the groups. There were no significant differences 
between the groups with regard to the postoperative recovery, pain or the length of the 
postoperative hospital stay. 
Conclusions : The present study demonstrated the safety and feasibility of the early removal of 
prophylactic drains in selected patients undergoing DG or PPG for gastric cancer. 
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Introduction 
In gastroenterological surgery, drains are routinely placed in order to remove blood, lymph 
and other exudates that may have accumulated after surgery, and these placed drains 
might also allow for early recognition of postoperative complications 1. 21• Furthermore, some 
postoperative complications may be treated successfully using surgically placed drains. On 
the other hand, recent advances in surgical techniques and devices, and improvements in 
perioperative management, have reduced the incidence of postoperative complications after 
gastrectomy, and the use of drains in itself can cause complications such as organ damage, 
infection, adhesions and pain 141• In these contexts, there has been much debate concerning 
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appropriate drain management. 
Some randomized clinical trials have failed to show any benefit from prophylactic drain 
placement, and suggested that routine drain insertion is unnecessary after gastrectomy with 
lymphadenectomy 5'71• In addition, recent reviews and meta-analyses also failed to demonstrate 
evidence to support the use of prophylactic drains in gastrectomy s. 91• However, in Japan, the 
prophylactic placement of drains during gastrectomy is still a common practice. In addition, 
once a drain has been placed, there is controversy among surgeons as to when to remove it, 
and the optimal timing of drain removal has been unclear. The present study was performed to 
determine the optimal timing of removal of prophylactic drains after distal gastrectomy (DG) or 
pylorus-preserving gastrectomy (PPG) for gastric cancer, and the present study also compared 
the surgical outcomes between patients in whom drains were removed during the early 
postoperative period and patients treated with the conventional drain management. 
Patients and methods 
Before this study, prophylactic drains were generally removed on postoperative day (POD) 
3 or later in patients who underwent DG or PPG, based on a physical examination and the 
aspects of the drainage fluid. In the present study, we compared the surgical outcomes 
between the group of patients where the drain was removed in the morning of POD 1 (early 
removal group) and the group where the drain was removed on POD 3 or later (control group). 
This prospective randomized clinical trial was conducted in the Department of Surgery, N ara 
Medical University, and was approved by the Local Ethics Committee on Clinical Investigation 
of Nara Medical University Hospital (No. 641). All patients undergoing DG or PPG with lymph 
node dissection for gastric cancer were eligible for this study. Written informed consent was 
obtained from all patients before the operation. The exclusion criteria were (1) combined organ 
resection (e.g., gall bladder and colon); (2) the use of postoperative anticoagulant therapy and (3) 
intraoperative injury of other organs and/or intraoperative anastomotic problems. Just after the 
operation, eligible patients were randomly assigned to either the early removal group or the 
control group using sealed envelopes made in blocks of 20. 
Perioperative management 
The surgical procedure and extent of lymph node dissection generally followed the Japanese 
Gastric Cancer Treatment Guidelines 2010 (version 3) 101• Perioperative management was 
performed as reported previously lll_ Briefly, all patients received a prophylactic antibiotic 
(Cefamezin alpha) before skin incision, and an additional dose was administered when the 
operation exceeded 3 hours. All antimicrobial prophylaxes were discontinued within 24 hours 
after the operation. After completion of the intestinal reconstruction, at least one drain was 
routinely placed at the superior margin of the pancreas. A 6.5-mm silicon multi-channel drain 
with a closed-suction reservoir (Covidien, Mansfield, MA, USA) was used during the period 
from January 2012 to November 2012. From December 2012, a 20-F thoracic catheter (Covidien) 
connected to a closed non-suction system was principally used. Epidural patient-controlled 
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analgesia (PCA) was principally used in patients undergoing open gastrectomy for postoperative 
pain, while intravenous patient-controlled analgesia (IVPCA) was used in patients undergoing 
laparoscopic gastrectomy. In all patients, the amylase concentrations of the drainage fluid 
(D-AMY) were measured in the morning of POD 1. 
In the control group, the drain was removed as described above. In the early removal group, 
the drain was removed in the morning of POD 1 before knowing the D-AMY level; however, 
the drain was left in place when abnormal discharge was present, and was only removed 
when the surgeon judged the drainage to be insignificant. In both groups, the postoperative 
management was based on the standard practices of our institution; the patients who 
underwent DG or PPG were permitted to drink water on POD 3 and to eat a soft diet on POD 
4 until April 2012. From April 2012, the patients were permitted to drink water on POD 1 and 
to eat a soft diet on POD 3. 
Outcome assessment 
The baseline patient characteristics evaluated in each group included the age, sex, body 
mass index (BMI), the American Society of Anesthesiologists (ASA) score, the presence of 
comorbidities, the use of preoperative chemotherapy and the clinical tumor stage according to 
the seventh edition of the American Joint Committee on Cancer TNM classification system 121• 
The following surgical data were also included: the approach (open or laparoscopic), the extent 
of lymph node dissection, the method used for reconstruction, the duration of surgery, the 
amount of blood loss and the need for a transfusion. 
We recorded and evaluated the incidence of postoperative complications for at least 30 
days after surgery. The rate of overall postoperative complications was defined as the 
primary endpoint of the study. The severity of complications was defined according to 
the Clavien-Dindo classification 131• An intra-abdominal abscess was defined as described 
previously 111• Delayed gastric emptying (DGE) was diagnosed as reported previously 141. 
Briefly, DGE was diagnosed when the following were noted: (1) the presence of symptoms 
such as nausea, vomiting or abdominal fullness, and (2) starting a solid diet after POD 7 or 
the need for re-fasting. In addition, several surgical outcomes were measured, including 
the time to first flatus and first walking, the use of analgesics other than PCA, delayed 
initiation of water and soft diet intake and postoperative changes in the serum total protein 
level, serum albumin level, white blood cell count and serum C-reactive protein level. 
Statistical analysis 
The analyses were performed on an intent-to-treat basis. Continuous variables were 
expressed as the medians and ranges, and the medians were compared using the Mann-
Whitney U test. Categorical variables were presented as numbers and percentages, and the 
groups were compared using the chi-square test or Fisher's exact test. A value of P <0.05 was 
considered to be significant. The statistical analyses were performed using the SPSS® software 
program, version 19.0 (SPSS, Chicago, IL). 
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Results 
The trial profile is shown in Fig. 1. A total of 132 patients with histologically confirmed 
gastric cancer underwent DG or PPG between February 2011 and September 2013. Of these 
132 patients. 32 patients met the exclusion criteria due to combined organ resection (n = 18), 
the use of postoperative anticoagulant therapy (n = 10), intraoperative organ injury (n = 3) or 
intraoperative anastomotic problems (n = 1). Therefore, 100 eligible patients were randomized 
to either the early removal group (n = 50) or the control group (n = 50), and all were available 
for the analysis. In all 100 patients, one drain was placed at the superior margin of the pancreas. 
Among the 50 patients in the early removal group, the drain was removed on POD 1 in 49 
patients. In one patient, the drain was left in place because blood discharge from the drain 
was evident, and the drain was removed on POD 2 because of a lack of evidence of continuous 
bleeding. Among the 50 patients in the control group, the drain was removed on POD 3 in 45 
patients, on POD 4 in two patients and on POD 5 in one patient. The drain was removed on 
POD 1 in one patient and on POD 2 in one patient because of drain-related pain. 
The baseline characteristics of both groups are shown in Table 1. The median age was 
Ineligible (11 ~ 32) 
Combined organ resection (n = 18) 
Gallbladder (11 ~ 13) 
Colon (11~4) 
Ovary (11 ~I) 
Anticoagulant therapy (11 = 10) 
Organ injury (11 ~ 3) 
Duodenum (n = 2) 
Pancreas (n = 1) 
Anastomotic trouble (n = 1) 
Drain removal 
POD l (n~ I) 
POD2 (n~ I) 
POD 3 (11~45) 
POD4(11~ 3) 
Fig. 1. The patient flow chart. DC distal gastrectomy, PPG pylorus-preserving 
gastrectomy, POD postoperative day 
significantly higher in the early removal group than in the control group, while both groups 
were comparable with respect to the sex, BMI, ASA score, presence of comorbidities, use of 
preoperative chemotherapy and clinical tumor stage. 
The perioperative data are shown in Table 2. There were no significant differences between 
the groups in terms of the surgical approach, extent of lymph node dissection, method used for 
reconstruction, duration of the operation, blood loss, transfusion and the D-AMY level on POD 
1. 
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Table 1. The baseline characteristics of the patients 
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ASA score, n (%) 





Chronic renal disease 
Pulmonary disease 
Steroid use 
Preoperative CTx, n (%) 
Clinical turn or stage, n (%) 
0,1A,1B 
llA,llB 
liiA, lllB, ll!C 








































B.Ml body mass index, ASA American Society ofAnesthesiologists, CTx chemotherapy 
aThe values are expressed as the medians with ranges 
Table 2. The perioperative data 
Approach, n (%) 
Open 
Laparoscopic 
LN dissection, n (%) 
Dl orDl+ 
D2 or more 




Duration of the operation (mint 
Blood loss (mL)a 
Transfusion, n (%) 
Drain amylase level on POD 1 (UIL)n 
LN1ymph node, POD postoperative day 
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Postoperative complications 
The incidence of postoperative complications is shown in Table 3. The rate of overall 
postoperative complications was 18% in the early removal group and 18% in the control 
group, with no significant difference between the groups (P >0.999). The incidence of severe 
complications (grade Ilia or greater) was also similar between the groups. One patient in the 
early removal group died of aspiration pneumonia 142 days after gastrectomy. One patient in 
the control group developed a superficial surgical site infection requiring incisional drainage 
under local anesthesia. Two patients, one in each group, had an intra-abdominal abscess that 
resulted from a pancreatic fistula, and these patients were successfully treated with antibiotics. 
No patients required secondary procedures, such as reoperation or radiological or endoscopic 
intervention. 
Table 3. The postoperative complications 
Early removal group Control group 
(n ~50) (n~SO) P value 
Total,n(%) 9 (18) 9 (18) >0.999 
Intra-abdominal abscess, n (%) I (2) I (2) 
DGE,n(%) 6 (12) 2 (4) 
Superficial incisional SST, n (%) 0 (0) 1 (2) 




Bleeding, n (%) 1 (2) 2 (4) 
Tntracorporeal 
Drain site 
Medical, n (%) I (2) 2 (4) 
Clavien-Dindo classification, n (%) 
I (2) 3 (6) 
11 7 (14) 5 (10) 
Ilia 0 (0) I (2) 
V I (2) 0 (0) 
DGE delayed gastric emptying, SS! surgical site infection 
Postoperative clinical course 
The postoperative clinical course of each group is shown in Table 4. There were no 
significant differences between the groups in terms of the day until first flatus and first walking, 
the analgesic use, the delayed initiation of water intake and a soft diet, the postoperative serum 
total protein level, serum albumin level, white blood cell count or the serum C-reactive protein 
level. The median length of postoperative hospital stay was 11 days in the early removal group 
and 11 days in the control group, with no significant difference between the groups (P = 0.612). 
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Table 4. The surgical outcomes 
Early removal group Control group 
(n~ 50) (n~SO) Pvalue 
First flatus, PODu 3 (1--6) 3 (1--6) 0.925 
First walking, PODa 1 (1-4) 1 (1-2) 0.402 
Analgesic usea 0 (0-8) 0 (0-11) 0.916 
Delayed initiation of water intake, n (%) 2 (4) 4 (8) 0.339 
Delayed initiation of soft diet, n (%) 0 (0) 4 (8) 0.059 
Serum total protein level (g/dL)" 
POD! 5.4 (4--6.9) 5.3 (3.8--6.3) 0.592 
POD3 6.1 (4.8-7.3) 5.8 (4.6-7.3) 0.116 
POD7 6.45 (4.8-7.7) 6.4 (4.8-7.6) 0.966 
Serum albumin level (g/dL)" 
POD! 3.15 (2.2-4.7) 3.3 (2-3.9) 0.673 
POD3 3.4 (1.9-4.2) 3.25 (2.4-4) 0.427 
POD7 3.65 (2.6-4.7) 3.75 (2.4-4.5) 0.493 
White blood cell count (/IlL)" 
POD! 9,850 (3,700-16,200) 9,000 (4,800-15,900) 0.799 
POD3 8,000 (3,400-12, 1 00) 6,700 (3,400-15,200) 0.085 
POD7 6,200 (2,700-12,900) 6,250 (3,400-11,000) 0.238 
C-reactive protein (mgldL)" 
POD 1 5.85 (1.6-12. 7) 5.75 (1.6-12.9) 0.707 
POD3 7.95 (1.3-21.7) 8.2 (0.8-26.3) 0.817 
POD7 2.15 (0.1-10.5) 2.55 (0.2-10.7) 0.403 
Postoperative hospital stay (days)" 11 (7-171) 11 (8-27) 0.612 
POD, postoperative day 
uThe values are expressed as the medians with ranges 
Discussion 
In this prospective randomized controlled study, we compared the surgical outcomes of 
patients treated with the early removal of the prophylactic drain with those who were treated 
with conventional drain management following DG or PPG for gastric cancer. We found no 
significant differences between the two treatment arms with regard to the rate of overall 
postoperative complications. Furthermore, none of the patients in either group required 
secondary interventions. These results indicate that early removal of the prophylactic drain 
may be safe and feasible in selected patients after DG or PPG for gastric cancer. 
One of the rationales behind the placement of drains is that the drain can provide an early 
warning sign of postoperative complications such as intra-abdominal bleeding, pancreatic 
fistula formation and anastomotic leakage. Early postoperative bleeding usually occurs during 
the first 24 hours postoperatively. Although intra-abdominal bleeding has been reported to 
be rare 15-171, massive bleeding can lead to a serious or fatal condition. Recently, some studies 
demonstrated that the use of a prophylactic drain did not provide any additional benefit for 
patients undergoing gastrectomy, and advocated that such postoperative complications can be 
diagnosed by clinical and radiological findings 7' 181• However, it seems premature to conclude 
that omitting drains after gastrectomy is safe, because those studies did not include a large 
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number of patients. In addition, the responses to such serious complications may be delayed in 
patients without drains. In the present study, postoperative intra-abdominal bleeding occurred 
in two patients (2%), one on the night of the operation and one in the morning of POD 2, and 
these patients were closely monitored. As a consequence, both patients required neither 
transfusion nor therapeutic interventions because they were hemodynamically stable. We 
believe that prophylactic drains might be meaningful for the early detection and immediate 
treatment of early postoperative bleeding to avoid mortality. 
From the viewpoint of the severity of postoperative complications, the present study 
demonstrated the safety of early removal of the prophylactic drain in patients who underwent 
DG or PPG. Another role for drains is to treat postoperative complications, such as a pancreatic 
fistula and anastomotic leakage, if they occur. In I a pan, the placement and management of 
drainage tubes is generally considered to have an important role in the postoperative care of 
gastrectomy patients, because adequate management through well-placed drains may reduce 
or obviate the need for reoperations 19' 20). On the other hand, the incidence of intra-abdominal 
infectious complications has been reported to be less common in distal gastrectomy than in 
total gastrectomy 21' 22). Furthermore, in the event of such complications, patients without a 
drain in place can still be treated by interventional radiology 23' 24). In the present study, one 
patient in each group had an intra-abdominal abscess associated with a pancreatic fistula. Both 
complications were diagnosed after the drain removal. and these patients were successfully 
treated without the need for radiological intervention. These data suggest that early drain 
removal may be safe in the patients who undergo DG or PPG, except in cases with evidence 
of intraoperative adjacent organ injury or anastomotic problems. In such cases, the drain is 
therapeutic but not prophylactic. 
The surgically placed drain itself can cause intra-abdominal infectious complications by 
providing a route for ascending infections. Kawai et al. reported that early removal of surgically 
inserted drains reduced the incidence of ascending infections, and reduced subsequent 
intra-abdominal infections, including intra-abdominal abscess formation and infected intra-
abdominal accumulation, and further showed that a longer period of drain insertion was an 
independent risk factor for such complications in patients undergoing pancreatic head resection 
25). We recently investigated the impact of bacterial culture positivity of the drainage fluid 
on the subsequent development of an intra-abdominal abscess in gastrectomy patients, and 
demonstrated that the patients with positive bacterial cultures on POD 1 had a significantly 
higher percentage of intra-abdominal abscesses than those with negative cultures, especially 
among the patients with a higher D-AMY level 11). Furthermore, bacterial culture positivity 
of the drainage fluid on POD 1 was the only independent risk factor for intra-abdominal 
abscess formation in patients without anastomotic leakage after gastrectomy. The presence 
of bacteria, in addition to a high D-AMY level. seems to be crucial for intra-abdominal abscess 
formation after gastrectomy. In addition, it is widely recognized that the incidence of drain-
fluid infection is increased when drain placement is prolonged 1. 3' 26). Therefore, long-term drain 
placement itself may contribute to the incidence of intra-abdominal infectious complications 
after gastrectomy, and prophylactic drains should be removed as early as possible to prevent 
such complications in patients undergoing gastrectomy. In the present study, we found no 
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significant difference in the incidence of intra-abdominal infectious complications between the 
groups, probably due to the relatively small number of patients included and the relatively 
short duration of the drain insertion in the control group. 
The placement and prolonged use of drains themselves can also contribute to increased 
postoperative pain, preventing deep inspiration and preventing ambulation 4' 271. Previous 
studies reported that gastrectomy patients with a drain used analgesics more frequently and 
resumed eating and passed flatus significantly later compared with those without the drain 5· 
181• The postoperative hospital stay was also significantly longer in the patients with the drain 
than in those without the drain 61• In addition, a previous study reported that 7.1% of patients 
developed drain-related complications after subtotal gastrectomy 71• In the present study, there 
were no significant differences between the groups in terms of the incidence of postoperative 
pneumonia, time to first flatus and first walking, analgesic use or the length of the postoperative 
hospital stay, while we found some drain-related complications. Two patients in the control 
group had severe drain-related pain. Their drains were removed on POD 1 and POD 2, and 
the pain disappeared completely. In one patient, drain site bleeding occurred in the morning of 
POD 1. He developed anemia on POD 2, but did not require a transfusion because his vital signs 
were stable. Taken together, these findings indicate that the early removal of the prophylactic 
drain may contribute to accelerating the postoperative physiological recovery, and seems to be 
essential for enhanced recovery after surgery protocols. 
In conclusion, the present study demonstrated the safety and feasibility of the early removal 
of the prophylactic drain in selected patients after DG or PPG for gastric cancer. However, the 
present study is associated with some limitations because the number of patients included was 
small. Further studies are needed to validate our results. 
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